Floracia Healthcare Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimiflo MV 2 Tablet PR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet PR
Glimiflo MV 2 Tablet PR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Use it as advised by your doctor or check the label for directions before use. Glimiflo MV 2 Tablet PR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimiflo MV 2 Tablet PR.
Glimiflo MV 2 Tablet PR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimiflo MV 2 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimiflo MV 2 Tablet PR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly.
Glimiflo MV 2 Tablet PR contains a combination of three medications: Glimepiride, Metformin, and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken with proper diet and exercise. Glimepiride lowers blood glucose by stimulating insulin release from the pancreas, while Metformin reduces glucose production in the liver and enhances insulin sensitivity. Voglibose acts as an alpha-glucosidase inhibitor to lower postprandial (after meal) glucose levels.
Possible side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. It's important to seek medical attention if any severe or unusual symptoms occur.
Glimiflo MV 2 Tablet PR is contraindicated for individuals with known allergies to the medication’s ingredients or excipients. It's also not recommended for patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis including diabetic ketoacidosis.
No, consuming alcohol while taking Glimiflo MV 2 Tablet PR is not recommended. Alcohol can worsen hypoglycemia and increase the risk of lactic acidosis.
Yes, Glimiflo MV 2 Tablet PR may lead to hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely if you miss meals, drink alcohol, over-exercise, or combine it with other antidiabetic medications. Regular blood sugar monitoring is crucial to manage this risk. Keep glucose tablets, honey, or fruit juice readily available at all times.
Store Glimiflo MV 2 Tablet PR in its original packaging tightly closed. Refer to the label or package for specific storage details. Discard unused medication. Do not share this medication with others, especially pets, children, or anyone else.